| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 98.803 | 96.183 | 134.763 | 129.827 | 134.808 | 104.614 | 107.892 | 169.403 | 163.815 | 160.657 |
| Total Income - EUR | 99.300 | 96.561 | 134.783 | 129.829 | 134.810 | 106.396 | 107.892 | 169.403 | 163.821 | 160.657 |
| Total Expenses - EUR | 57.045 | 53.548 | 57.721 | 57.624 | 68.464 | 48.243 | 55.866 | 110.230 | 99.191 | 95.201 |
| Gross Profit/Loss - EUR | 42.256 | 43.013 | 77.061 | 72.205 | 66.346 | 58.153 | 52.026 | 59.173 | 64.631 | 65.455 |
| Net Profit/Loss - EUR | 35.495 | 36.131 | 75.774 | 70.907 | 64.997 | 57.089 | 50.947 | 57.142 | 62.992 | 60.732 |
| Employees | 13 | 13 | 11 | 12 | 1 | 1 | 15 | 16 | 16 | 16 |
Check the financial reports for the company - Alfamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 126.113 | 120.780 | 127.352 | 120.452 | 112.289 | 105.444 | 99.904 | 95.980 | 93.027 | 92.289 |
| Current Assets | 75.289 | 77.977 | 10.373 | 11.461 | 75.321 | 75.008 | 70.481 | 76.525 | 89.245 | 86.341 |
| Inventories | 0 | 0 | 0 | 1.330 | 0 | 0 | 37.271 | 0 | 0 | 0 |
| Receivables | 6.687 | 7.531 | 9.426 | 9.621 | 8.630 | 25.143 | 4.594 | 3.912 | 14.927 | 40.858 |
| Cash | 68.602 | 70.446 | 947 | 509 | 66.691 | 49.865 | 28.617 | 72.613 | 74.318 | 45.483 |
| Shareholders Funds | 197.593 | 196.586 | 128.997 | 123.153 | 116.233 | 171.118 | 162.448 | 169.054 | 174.566 | 171.682 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.198 | 2.284 | 8.883 | 8.760 | 71.378 | 9.333 | 7.937 | 3.451 | 7.706 | 6.948 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Alfamed Srl